MIAMI, FL, May 24, 2023 (GLOBE NEWSWIRE) — Veru Inc. VERU, a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of breast cancer and for SARS-CoV-2 and other viral ARDS-related diseases, today announced that Mitchell Steiner, M.D., Chairman, President and Chief Executive Officer of Veru,…Read More
Veru to Present at the Jefferies Healthcare Conference Veru NASDAQVERU
